FindTrial
Sign In

Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA - - WITEVA

Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA - - WITEVA

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-003473-27-DE
Enrollment
Unknown
Registered
2006-10-19
Start date
2007-04-16
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Trade Name: Diovan 80/160 Kinzal 40/80 Product Name: Diovan / Kinzal Product Code: BAY69-9291 Pharmaceutical Form: Tablet INN or Proposed INN: Diovan 80mg CAS Number: 50477.00.00 Current Sponsor code:

Sponsors

MedQuality Forschung GmbH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: age > 18 essential hypertension (RRsyst.>140,RRdiast.>90 mmHG) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Creatinine Clearance < 30 ml /min severe cardiac insufficiency (NYHY IV) severe aortic stenosis acute myocardial infarction within last 4 weeks unstable angina pregnancy participation in another clinical trial within last 30 days

Design outcomes

Primary

MeasureTime frame
Primary end point(s): HOMA-index (begin and after 12 weeks) pulse-pressure (begin and after 12 weeks) trough-to-peak-blood-pressure (begin and after 12 weeks);Main Objective: Investigation of the effects on insuline sensitivity (HOMA-index);Secondary Objective: trough-to-peak-bloodpressure, pulse-pressure—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026